| 6:45 a.m. |
Registration |
| 7:30 a.m. |
Introduction by Moderators |
| 7:35 a.m. |
2014 Harry Hirsch Leiter Award Recipient: R.A. Eiferman
Put The Preservative In The Bottle, Not In The Eye!
|
| 7:43 a.m. |
1. Epidemiology of Herpes Zoster Ophthalmicus: Recurrence and Chronicity
Kimberly D. Tran, MD |
| 7:50 a.m. |
2. Development of Herpes Zoster Ophthalmicus after Herpes Zoster Vaccination
Shruti Aggarwal, MD |
| 7:57 a.m. |
3. Effect of Corneal Scar Location in Patients with Herpes Simplex Keratitis on Bilateral Corneal Nerve Alteration: An In Vivo Confocal Microscopy Study
Chareenun Chirapapaisan, MD |
| 8:04 a.m. |
4. Is Benzalkonium Chloride (BAK) Effective against Adenovirus?
Eric Romanowski |
| 8:11 a.m. |
5. Epstein-Barr Virus-Associated Scleritis Responsive to Valganciclovir:
A Case Report
Robert Garoon, MD |
| 8:18 a.m. |
6. Staphylococcus Caprae Polymicrobial Keratitis
David J. Harris, III, MD |
| 8:25 a.m. |
7. Molecular Epidemiology of Ocular Staphylococcus aureus Infections
Paulo J. M. Bispo, PhD |
| 8:32 a.m. |
8. Staphylococcus aureus Keratitis: Multi-Locus Sequence Typing and Genome Sequencing to Identify Lineage, Virulence and Antibiotic Resistance Genes
Irmgard Behlau, MD |
| 8:39 a.m. |
9. Microbial Keratitis at an Urban Public Hospital: A 10-year update
David T. Truong, MD |
| 8:46 a.m. |
10. Ocular Pathogens and Antibiotic Sensitivity of Bacterial Keratitis Isolates at
King Khaled Eye Specialist Hospital, Saudi Arabia - 2011-2014
Donald U. Stone, MD |
| 8:53 a.m. |
11. Organ culture model for microbial keratitis in ex vivo rabbit and human corneas
Prashant Garg, MD |
| 9:00 a.m. |
12. Corneal Endothelial Safety in Far Ultraviolet Light (222 nm) Antimicrobial Ophthalmic Care
J. James Rowsey, MD |
| 9:07 a.m. |
13. Photodynamic Therapy-Potential as Alternative/Adjunctive Therapy
for MRSA Keratitis?
Darlene Miller, DHSc,MPH,CIC |
| 9:14 a.m. |
14. Intracameral Cross-Linked Hyaluronic Acid Plus Vancomycin—Sustained Release and the First Step Towards Effective Dropless Eye Surgery
Richard A. Eiferman, MD |
| 9:21 a.m |
BREAK |
| 9:36 a.m. |
15. Diffusion of Moxifloxacin across Corneal Collagen Shields
Kimberly Brothers, PhD |
| 9:43 a.m. |
16. The Role of Scleral Debridement in Infectious Scleritis
Laura A. Vickers, MD |
| 9:50 a.m. |
17. Changing Azole Susceptibility in the Mycotic Ulcer Treatment Trial I
N. Venkatesh Prajna, MD |
| 9:57 a.m. |
18. The effect of light exposure on the efficacy and safety of Amphotericin B in
Optisol-GS corneal storage media
Katherine Duncan |
| 10:04 a.m. |
19. Fungal endophthalmitis after Descemet Stripping Automated Endothelial Keratoplasty due to endogenously infected grafts from the same donor
Sotiria Palioura, MD |
| 10:11 a.m. |
20. Candida interface infections among a cluster of positive fungal corneoscleral rim cultures used in Descemet's stripping automated endothelial keratoplasty
Edmund Tsui, MD |
| 10:18 a.m. |
21. Fungal Keratitis and Endophthalmitis after using Gamma-Irradiated Corneas as Carriers for Boston Type I Keratoprosthesis
Mansi D. Talati, MD |
| 10:25 a.m. |
22. Hypochlorous Acid: A Candidate Prophylactic Antifungal Agent for
Boston
Keratoprosthesis Patients
Silvia Odorcic, MD |
| 10:32 a.m. |
23. Initiation of systemic anti-neoplastic agents contributing to corneal transplant rejection?
A case series
Ashley Rohr, MD |
| 10:39 a.m. |
24. Pure 0.01% Hypochlorous Acid Cleanser without Sodium Hypochlorite Impurities for Treating Demodex Blepharitis
Kathryn Najafi-Tagol, MD |
| 10:46 a.m. |
25. Dry Eye Profiles in Patients with a Positive Elevated Surface Matrix Metallopeptidase 9 Point of Care Test versus Negative Patients
Victoria S. Chang, MD |
| 10:53 a.m. |
26. Features of neuropathic ocular pain in dry eye are associated with chronic comorbid pain syndromes (CPS)
Hatim Batawi, MD |
| 11:00 a.m. |
27. Low-dose topical preservative-free Dexamethasone 0.01% and 0.05% for treatment of chronic ocular surface disease unresponsive to commercially available steroids, antibiotics, and
anti-allergy agents
Adnan Mallick, MD |
| 11:07 a.m. |
28. Reduced Efficacy of Low-dose Topical Steroids in Dry Eye Disease Associated with Ocular GVHD
Ahmad Kheirkhah, MD |
| 11:20 a.m. |
Thygeson Lecture: New Insights Into the Pathogenesis of Fungal Keratitis
Eric Pearlman, PhD
Professor
Department of Ophthalmology and Department of Physiology and Biophysics
Director, Institute for Immunology University of California, Irvine
|
| 12:05 p.m. |
Closing Comments and Awards |
| 12:15 p.m. |
Business Luncheon - Genoa Room |
